Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis-Reference-Cited by-同舟云学术

Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis

Published:2017-04 Issue:4 Volume:103 Page:1142-1150
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Lococo Filippo,Rapicetta Cristian,Cardillo Giuseppe,Stefani Alessandro,Margaritora Stefano,Leuzzi Giovanni,Rossi Giulio,Petracca Ciavarella Leonardo,Morandi Uliano,Facciolo Francesco,Ricchetti Tommaso,Cesario Alfredo,Paci Massimiliano

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference25 articles.

1. Outcomes of sarcomatoid carcinoma of the lung: a Surveillance, Epidemiology, and End Results Database analysis;Yendamuri;Surgery,2012

2. Resection of a pleomorphic carcinoma of the lung invading the descending aorta;Sato;J Thorac Cardiovasc Surg,2004

3. Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease?;Venissac;J Thorac Cardiovasc Surg,2007

4. Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma;Lin;Am J Clin Oncol,2016

5. Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene;Pelosi;Lung Cancer,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung;Journal of Thoracic Oncology;2024-09

2. Effect of histological subtype on the efficacy of perioperative chemotherapy in pulmonary sarcomatoid carcinoma: a retrospective study based on SEER population;Translational Lung Cancer Research;2024-04

3. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review;Translational Lung Cancer Research;2024-03

4. Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review;Frontiers in Immunology;2023-10-23

5. Survival analysis and nomogram for pulmonary sarcomatoid carcinoma: an SEER analysis and external validation;BMJ Open;2023-10